PerpEquities

GenScript Biotech Corporation (GENSCRIPT) balance sheet

HKSE · Healthcare · Biotechnology · 6,135 employees · CEO Weihui Shao

Price
$3.54 0.0%
Market cap
$7.97B
Enterprise value
$8B Data as of 2026-11-21
Last report
Q2 '26 filed 2026-06-30
Next report
2027-03-24

At the end of Q2 '26 GenScript Biotech Corporation (GENSCRIPT) held $831M in cash and short-term investments against $255M of debt incl. leases. Total assets $4.79B, total liabilities $882M, shareholders' equity $3.88B.

Balance sheet

Balance sheetTrendQ4 '20Q2 '21Q4 '21Q2 '22Q4 '22Q2 '23Q4 '23Q2 '24Q4 '24Q2 '25Q4 '25Q2 '26
Assets
Cash & equivalents$629M$958M$1.18B$782M$1.02B$1.4B$1.45B$399M$132M$293M$174M$217M
Short-term investments$137M$243M$223M$458M$229M$500M$482M$1.47B$489M$104M$669M$614M
Receivables$142M$92.6M$142M$102M$104M$133M$219M$131M$119M$132M$134M$157M
Inventory$31.7M$34.9M$44.4M$49.9M$59.9M$51.5M$53.3M$50.9M$31.1M$38.8M$39.6M$45.2M
Other current assets$43.6M$41.3M$41.1M$89.9M$135M$139M$151M$147M$54.7M$67.5M$40.4M$45.9M
Current assets$993M$1.37B$1.64B$1.5B$1.76B$2.47B$2.35B$2.21B$835M$1.18B$1.06B$1.08B
Property, plant & equipment (net)$379M$437M$487M$549M$625M$686M$751M$814M$596M$598M$623M$651M
Long-term investments$14M$14.6M$18.5M$18.7M$16M$35.9M-$396M$96.7M$3.79B$3.61B$3.11B$2.99B
Goodwill$14.1M$14.1M$14.2M$14.1M$2.55M$2.5M$1.36M$1.35M$1.34M$1.34M$1.37M$1.41M
Intangible assets$26M$27.3M$26.4M$25.5M$23.8M$22.6M$18.6M$16.1M$13M$12.8M$13.3M$13.4M
Deferred tax assets$3.7M$3.09M$5.09M$6.34M$15M$16.5M$16.5M$15.1M$27.7M$18.7M$16.4M$12.9M
Other non-current assets-$3.7M-$3.09M-$5.09M-$6.34M-$15M-$16.5M$643M$190M$43.5M$36.9M$26.5M$38.4M
Non-current assets$433M$493M$546M$607M$667M$747M$1.03B$1.12B$4.44B$4.26B$3.8B$3.71B
Total assets$1.45B$1.89B$2.23B$2.14B$2.55B$3.38B$3.39B$3.33B$5.28B$5.43B$4.85B$4.79B
Liabilities
Accounts payable$23.4M$27.2M$30.2M$32.9M$55.8M$40.3M$40M$59.2M$29.8M$51.7M$36.8M$41.1M
Accrued expenses$114M$144M$156M$134M$210M$186M$165M$189M$69.9M$65.6M$55M$47.8M
Short-term debt$44.6M$20.5M$521K$6.7M$33.7M$35.2M$57M$31M$88.7M$155M$468M$193M
Taxes payable$8.36M$27.6M$15.8M$13.6M$16.2M$29.9M$25.6M$21.7M$14.7M$0$0$0
Deferred revenue-$47.2M-$25.3M-$8.03M-$14.1M-$44.8M-$44.7M$0$0$0$0$48.2M$64.4M
Other current liabilities$97.3M$224M$219M$332M$235M$167M$224M$240M$111M$319M$74.1M$363M
Current liabilities$328M$421M$413M$513M$546M$438M$495M$533M$307M$601M$720M$727M
Long-term debt$1.26M$18.2M$121M$190M$261M$271M$287M$846M$570M$330M$85.9M$90.1M
Lease obligations (non-current)$6.51M$12.3M$27.3M$25.6M$44M$65.6M$63.9M$97.6M$57M$54.8M$55M$51.5M
Deferred revenue (non-current)$289M$267M$258M$246M$18.2M$16.4M$48M$0$0$0$0$0
Deferred tax liabilities$7.03M$9.8M$7.73M$9.94M$8.01M$5.89M$5.62M$7.51M$5.84M$13.7M$14M$12M
Other non-current liabilities-$31.3M-$12.3M$233M-$9.44M$236M$435M$443M$30.9M$20.1M$28.1M$1.3M$1.29M
Non-current liabilities$1.26M$18.2M$382M$461M$567M$771M$848M$975M$648M$413M$156M$155M
Total liabilities$632M$729M$846M$1.26B$1.18B$1.3B$1.34B$1.51B$955M$1.01B$876M$882M
Equity
Common stock & paid-in capital$1.95M$2.08M$2.1M$2.11M$2.11M$2.12M$2.12M$2.13M$2.14M$2.18M$2.18M$2.19M
Retained earnings-$175M-$266M-$275M-$654M-$502M-$596M-$612M-$773M$2.36B$2.32B$1.8B$1.67B
Accumulated other comprehensive income$24.9M$35.9M$60.8M$64.4M$49.6M$34.1M$715M$19.3M-$20.6M$4.42B$177M$234M
Shareholders' equity$902M$1.01B$1.05B$757M$1.01B$1.35B$1.39B$1.21B$4.32B$4.42B$3.96B$3.88B
Debt
Total debt (incl. leases)$55M$55.8M$156M$229M$350M$381M$417M$989M$724M$549M$259M$255M
Net debt (debt - cash)-$574M-$902M-$1.02B-$553M-$674M-$1.02B-$1.03B$590M$592M$255M$116M$37.3M

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings.

Data as of 2026-11-21